Hap Trading, LLC Axsome Therapeutics, Inc. Put Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	BUY	$78.93 - $95.84 $1.55 Million - $1.89 Million	19,700 New	19,700 $52.2 Million
Q2 2022 Aug 12, 2022	SELL	$21.74 - $46.75 $69,568 - $149,600	-3,200 Reduced 23.53%	10,400 $74,000
Q3 2021 Nov 10, 2021	SELL	$19.91 - $68.26 $11,946 - $40,956	-600 Reduced 4.23%	13,600 $320,000
Q2 2021 Aug 11, 2021	SELL	$50.63 - $73.5 $931,592 - $1.35 Million	-18,400 Reduced 56.44%	14,200 $139,000
Q1 2020 May 08, 2020	BUY	$41.2 - $101.31 $1.34 Million - $3.3 Million	32,600 New	32,600 $91,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.